Cargando…

Direct oral anticoagulant (DOAC) monitoring within primary care: a quality improvement project

BACKGROUND: Poor monitoring of anticoagulants is a significant area of patient safety. It can lead to the dichotomous risk of haemorrhage/clotting without appropriate counselling and monitoring. While healthcare professionals may be familiar with the anticoagulant warfarin and the international norm...

Descripción completa

Detalles Bibliográficos
Autores principales: McFadzean, Isobel Joy, Francis, Rhian, Fischetti, Catrin, Morton, Vanessa, Goodfellow, Susan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10254955/
https://www.ncbi.nlm.nih.gov/pubmed/37263737
http://dx.doi.org/10.1136/bmjoq-2022-002216
_version_ 1785056763771355136
author McFadzean, Isobel Joy
Francis, Rhian
Fischetti, Catrin
Morton, Vanessa
Goodfellow, Susan
author_facet McFadzean, Isobel Joy
Francis, Rhian
Fischetti, Catrin
Morton, Vanessa
Goodfellow, Susan
author_sort McFadzean, Isobel Joy
collection PubMed
description BACKGROUND: Poor monitoring of anticoagulants is a significant area of patient safety. It can lead to the dichotomous risk of haemorrhage/clotting without appropriate counselling and monitoring. While healthcare professionals may be familiar with the anticoagulant warfarin and the international normalised ratio, they might be unaware of the monitoring requirements of direct oral anticoagulants (DOACs), despite DOACs making up 62% of anticoagulants prescribed. The goal of this quality improvement (QI) project was to increase the compliance of monitoring of DOACs within general practice (GP) to improve patient safety and reduce the risk of an adverse outcome for patients. LOCAL PROBLEM: In 2019, the GP surgery had 318 patients prescribed a DOAC and their medication reviews took place opportunistically. While initially, monitoring levels were nearly 100%, by December 2018 this had dropped significantly, and clinicians stated they were unfamiliar with this medication. METHODS AND INTERVENTIONS: This project aimed to resolve this by using QI methodology and Plan–Do–Study–Act (PSDA) cycles to create new sustainable processes with DOAC monitoring and aimed to increase DOAC monitoring by 20% within 6 months. RESULTS: Within 6 months, the project improved the rate of monitoring, and 49% of all patients prescribed a DOAC were seen in a DOAC clinic (n=156) and 78% (n=230/294) had DOAC counselling; 97% (n=295/304) had appropriate blood tests and 72% (n=216/298) had a recent weight recorded within their medical records. Three years on, 600 patients within the practice are prescribed DOACs and 74% (n=445) have had an annual review adhering to the gold standards set within the project. CONCLUSION: This QI project confirms that monitoring of DOACs can be improved within primary care by using QI methodology and improving patient safety, using PDSA cycles, stakeholder engagement and the introduction of the anticoagulant domains within the nationwide Quality Assurance and Improvement Framework.
format Online
Article
Text
id pubmed-10254955
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-102549552023-06-10 Direct oral anticoagulant (DOAC) monitoring within primary care: a quality improvement project McFadzean, Isobel Joy Francis, Rhian Fischetti, Catrin Morton, Vanessa Goodfellow, Susan BMJ Open Qual Quality Improvement Report BACKGROUND: Poor monitoring of anticoagulants is a significant area of patient safety. It can lead to the dichotomous risk of haemorrhage/clotting without appropriate counselling and monitoring. While healthcare professionals may be familiar with the anticoagulant warfarin and the international normalised ratio, they might be unaware of the monitoring requirements of direct oral anticoagulants (DOACs), despite DOACs making up 62% of anticoagulants prescribed. The goal of this quality improvement (QI) project was to increase the compliance of monitoring of DOACs within general practice (GP) to improve patient safety and reduce the risk of an adverse outcome for patients. LOCAL PROBLEM: In 2019, the GP surgery had 318 patients prescribed a DOAC and their medication reviews took place opportunistically. While initially, monitoring levels were nearly 100%, by December 2018 this had dropped significantly, and clinicians stated they were unfamiliar with this medication. METHODS AND INTERVENTIONS: This project aimed to resolve this by using QI methodology and Plan–Do–Study–Act (PSDA) cycles to create new sustainable processes with DOAC monitoring and aimed to increase DOAC monitoring by 20% within 6 months. RESULTS: Within 6 months, the project improved the rate of monitoring, and 49% of all patients prescribed a DOAC were seen in a DOAC clinic (n=156) and 78% (n=230/294) had DOAC counselling; 97% (n=295/304) had appropriate blood tests and 72% (n=216/298) had a recent weight recorded within their medical records. Three years on, 600 patients within the practice are prescribed DOACs and 74% (n=445) have had an annual review adhering to the gold standards set within the project. CONCLUSION: This QI project confirms that monitoring of DOACs can be improved within primary care by using QI methodology and improving patient safety, using PDSA cycles, stakeholder engagement and the introduction of the anticoagulant domains within the nationwide Quality Assurance and Improvement Framework. BMJ Publishing Group 2023-06-01 /pmc/articles/PMC10254955/ /pubmed/37263737 http://dx.doi.org/10.1136/bmjoq-2022-002216 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Quality Improvement Report
McFadzean, Isobel Joy
Francis, Rhian
Fischetti, Catrin
Morton, Vanessa
Goodfellow, Susan
Direct oral anticoagulant (DOAC) monitoring within primary care: a quality improvement project
title Direct oral anticoagulant (DOAC) monitoring within primary care: a quality improvement project
title_full Direct oral anticoagulant (DOAC) monitoring within primary care: a quality improvement project
title_fullStr Direct oral anticoagulant (DOAC) monitoring within primary care: a quality improvement project
title_full_unstemmed Direct oral anticoagulant (DOAC) monitoring within primary care: a quality improvement project
title_short Direct oral anticoagulant (DOAC) monitoring within primary care: a quality improvement project
title_sort direct oral anticoagulant (doac) monitoring within primary care: a quality improvement project
topic Quality Improvement Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10254955/
https://www.ncbi.nlm.nih.gov/pubmed/37263737
http://dx.doi.org/10.1136/bmjoq-2022-002216
work_keys_str_mv AT mcfadzeanisobeljoy directoralanticoagulantdoacmonitoringwithinprimarycareaqualityimprovementproject
AT francisrhian directoralanticoagulantdoacmonitoringwithinprimarycareaqualityimprovementproject
AT fischetticatrin directoralanticoagulantdoacmonitoringwithinprimarycareaqualityimprovementproject
AT mortonvanessa directoralanticoagulantdoacmonitoringwithinprimarycareaqualityimprovementproject
AT goodfellowsusan directoralanticoagulantdoacmonitoringwithinprimarycareaqualityimprovementproject